Furqan Ahmed

Furqan Ahmed currently serves as VP and Head of Business Development at Biosion, a position held since July 2023. Prior experience includes roles as VP of Business Development at Immunome, Inc. from November 2021 to June 2023, and Director of Corporate Strategy and Business Development at Eisai US from December 2018 to November 2021, where responsibilities also encompassed Business Development and Alliances in the Oncology Business Group. Previous roles include Associate Director positions at Antares Pharma Inc. and Merck, where contributions spanned Business Development, Corporate Development, and various scientific specialist roles. Furqan began a career in the pharmaceutical industry as a Regulatory Affairs Intern at Schering Plough and an Equity Research Intern at Needham & Company. Education was completed at Rutgers Pharmacy with a PharmD degree obtained in 2008.